LX1
Product Specifications
CAS Number
2647877-84-5
Target
Androgen Receptor|||Reductase
Related Pathways
Metabolism|||Endocrinology/Hormones
Bioactivity
LX1, an anti-prostate cancer compound, specifically targets the androgen receptor (AR), AR variants, and the steroidogenic enzyme AKR1C3. It inhibits AKR1C3's enzymatic function, decreases the conversion of androstenedione to testosterone, and reduces the expression of both AR and AR-V7, subsequently downregulating their target genes. Additionally, LX1 is effective in overcoming tumor cell resistance to Enzalutamide, and when combined with Enzalutamide, it further suppresses tumor growth.
Smiles
O=C(NC=1C=C(C=C(C1)C(F)(F)F)C(F)(F)F)C2=CC(=CC=C2O)CC=3C=CC=CC3
Molecular Formula
C22H15F6NO2
Molecular Weight
439.35
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS438870-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
p21WAF1 (Tumor Suppressor Protein) Mouse Monoclonal Antibody
Ask
View Details MBS438870-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
p21WAF1 (Tumor Suppressor Protein) Mouse Monoclonal Antibody
Ask
View Details 
MBS438870-03 0.1 mg (Without BSA & Azide at 1mg/mL)
p21WAF1 (Tumor Suppressor Protein) Mouse Monoclonal Antibody
Ask
View Details MBS438870-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
p21WAF1 (Tumor Suppressor Protein) Mouse Monoclonal Antibody
Ask
View Details